Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PFE - Blueprint Medicines: Conviction In Precision Oncology

PFE - Blueprint Medicines: Conviction In Precision Oncology

Pfizer Inc.

Note: This article was first revealed to subscribers to my exclusive marketplace, The Formula, in February when shares of Blueprint were trading < $80.

Preface

Documents: 10-Q | Company Slides

Shares: 48,853,933 | PPS: $100 | Market Cap: $4.8B | Enterprise Value:~$4.4B | Cash/Investments: ~$400M | Cash Runway: into 2021

BPMC Idea Slides

Pipeline Overview

1. Avapritinib - KIT and PDGFRA inhibitor

  • GIST - 2nd line (late-stage trial planned in 1H 2019)
  • GIST - 3rd line (NDA planned in 2020)
  • GIST - 4th line (NDA planned in 1H 2019)
  • Advanced

Read more ...
Stock Information
Company Name: Pfizer Inc.
Stock Symbol: PFE
Market: NYSE
Website: pfizer.com
Menu
PFE PFE Quote PFE Short PFE News PFE Articles PFE Message Board
Get PFE Alerts

News, Short Squeeze, Breakout and More Instantly...